GlassScriptPhysician profile
Kara L Klinglesmith
NPI 1376182253
$1,287.63
in general payments reported to CMS, 2019-2025
19 companies · $363 in 2025
The $363 reported for 2025 was more than what 92% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.23 · 2022: $324 · 2023: $386 · 2024: $160 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $908.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $288.12 | 2022-2025 | |
| Organon LLC | $123.17 | 2022-2025 | Nexplanon, Jada System |
| Abbvie INC. | $110.99 | 2021-2023 | |
| Agile Therapeutics, INC. | $107.92 | 2022-2023 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $91.54 | 2021-2023 | |
| Myriad Women'S Health, INC. | $88.84 | 2023 | Myrisk |
| Astellas Pharma US INC | $67.10 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $64.33 | 2024-2025 | Aptima, Acessa Provu System |
| Sumitomo Pharma America, INC. | $54.22 | 2025 | Myfembree |
| Millicent US INC | $52.39 | 2024-2025 | Intrarosa, Femlyv |
| Therapeuticsmd, INC. | $51.67 | 2022 | |
| Mylan Pharmaceuticals INC. | $49.87 | 2022 | |
| Gynesonics, INC. | $24.68 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Evofem Biosciences, INC. | $23.67 | 2022 | |
| Convatec INC. | $22.13 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $21.88 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.20 | 2022 | |
| Exeltis, USA INC. | $15.00 | 2025 | Slynd |
| Pfizer INC. | $14.91 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara Klinglesmith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.